6α-HYDROXY PACLITAXEL - AN OVERVIEW

Truqap is really a kinase inhibitor that actually works by blocking pathways that assistance the most cancers cells survive and mature, so lessens most cancers development. Truqap is from a category of medicines named an AKT inhibitor. Truqap acquired FDA approval on November 17, 2023, after positive success from the CAPItello-291 Section III trial